Explorer les evidences

0,6 %According to data from the Demographic and Health Surveys III 2016–2017, HIV seroprevalence in Burundi is 0.6% in men aged 15 to 49 years.

BurundiVIH/sidaobservé 2016–2017HAL · Unilimdocument de 62 observations

27,3 %As of 29 September 2024, children under five years of age constituted 27.3% of the total confirmed mpox cases in Burundi.

Burundimpoxobservé 29 September 2024Africa CDCdocument de 147 observations

6 250 contacts_tracedBurundi reported 6,250 cumulative mpox contacts traced, including 936 new contacts traced in week 39.

Burundimpoxobservé week 39Africa CDCdocument de 147 observations

The DRC, Uganda, Burundi, Kenya, and Rwanda serve as epicenters of ongoing mpox transmission.

Burundi · Kenya · Ouganda · RDC · RwandampoxAfrica CDCdocument de 110 observations

421 dischargesBurundi reported 421 cumulative mpox discharges, with 74 new discharges in week 39.

Burundimpoxobservé week 39Africa CDCdocument de 147 observations

3 countriesAs of the end of February 2025, three countries in the active phase — Burundi, Rwanda, and Central African Republic — were observing a declining trend in mpox transmission.

Burundi · Rwandampoxobservé end of February 2025Africa CDCdocument de 110 observations

50 000 test_kits50,000 test kits were delivered from Singapore to the Central African Republic, Burundi, and Uganda for Mpox diagnostics.

Burundi · OugandampoxAfrica CDCdocument de 72 observations

Burundi, CAR, Congo, DRC, Gabon, Kenya, Rwanda, and Uganda reported Clade I mpox cases.

Burundi · Gabon · Kenya · Ouganda · RDC · RwandaClade I · mpoxAfrica CDCdocument de 11 observations

16,4 %Burundi experienced a 16.4% increase in new suspected mpox cases in the past 6 weeks compared to the preceding 6 weeks.

BurundimpoxAfrica CDCdocument de 74 observations